The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This presentation will cover WuXi Biologics’ new biopharmaceutical contract manufacturing facility in Dundalk, Ireland, which has set industry benchmarks in time to market, scale, and flexibility. A unique approach to the process scope of supply was a key factor in this achievement. WuXi Biologics chose the largest available single use bioreactors (4,000L), a hybrid single-use/stainless steel process design, and an integrated approach for process design, manufacturing, installation, and commissioning. The result is a highly flexible, large-scale process that was turned over only 28 months after start of design, with much of the project occurring during the COVID-19 crisis. In this talk, we provide details of the process scope as well as the project execution approach.
Speaker(s):
Richard
Shah,
Project Lead, Associate Director,
WuXi Biologics
Scott
Brady,
Vice President, Project Management,
ABEC Inc.
You must be logged in and own this session in order to
post comments.